The science, made simple

The metabolic root of chronic disease

Very different diseases, often the same roots underneath. Explore the interactive Disease Map, then play through the science here.

Every claim links to a recent study.
0 conditions mapped 0 studies cited 0 shared roots
Open the Disease Map
One mechanism, many diseases

The Disease Map

Nineteen chronic conditions, from Alzheimer's to heart disease, traced back to the same metabolic roots, each tagged with where the evidence stands. We gave it room to breathe on its own page.

Open the interactive Disease Map →
Why this matters

A global problem, sharpest at home.

Chronic disease is now the world's biggest killer, and it is climbing fastest where diets have shifted most. The UK sits near the front of that curve.

Across the world
74%of all deaths worldwide are now from noncommunicable diseases: heart disease, cancer, diabetes and stroke. That is 41 million people a year.World Health Organization
828madults were living with diabetes in 2022, more than four times the number in 1990.NCD-RisC, The Lancet 2024
38%of adults worldwide now have fatty liver disease, a condition defined by its metabolic root.Younossi et al., 2024
And in the UK
54%of UK adults' calories come from ultra-processed food. For teenagers it is around two-thirds, among the highest rates anywhere.National Diet and Nutrition Survey; Cambridge and Bristol, 2024
~6mpeople in the UK now live with diabetes, an all-time high. One in five adults has diabetes or prediabetes.Diabetes UK, 2024-25
£10.7bnis what diabetes alone costs the NHS each year, most of it spent on complications.Diabetes UK

Around 90% of UK diabetes is type 2, the form most closely tied to diet. Steady glucose is the lever we can put on a shelf.

The honest version

How strong is the evidence?

Most health brands overstate. We would rather show you exactly how sure the science is. Every claim below is graded, from broad scientific consensus to genuinely contested. We lead with the strong stuff and flag the rest.

Each claim below is graded by how strong the evidence is: four bars means broad scientific consensus, one bar means a contested hypothesis.

ConsensusBroad scientific agreement.
  • Insulin resistance is the recognised upstream driver of cardiovascular disease, type 2 diabetes and fatty liver disease, often beginning years before diagnosis.

    Reaven, Diabetes 1988; Kosmas et al., 2023
  • Metabolic syndrome roughly doubles cardiovascular risk (relative risk 2.35 across about 951,000 people).

    Mottillo et al., J Am Coll Cardiol 2010
  • Fatty liver disease was formally renamed to hard-code its metabolic root, and now affects around 38% of adults worldwide.

    EASL-EASD-EASO 2024; Younossi et al., 2024
  • In a controlled NIH trial, an ultra-processed diet led people to eat around 500 more calories a day and gain weight, even when matched for sugar, fat and salt.

    Hall et al., Cell Metabolism 2019
  • Higher ultra-processed food intake is directly linked to 32 adverse health outcomes across nearly 10 million people.

    Lane et al., BMJ 2024
  • Each daily sugary drink raises type 2 diabetes risk by about 27%.

    Meng et al., Nutrients 2021
Well establishedStrong, consistent links; the exact mechanism is still being worked out.
  • Alzheimer's is increasingly described as "type 3 diabetes", reflecting insulin resistance in the brain.

    de la Monte 2008; Peng et al., Ageing Res Rev 2024
  • Type 2 diabetes raises Parkinson's risk by around 21%.

    Pooled meta-analysis, odds ratio 1.21
  • Obesity, high insulin and IGF-1 signalling are established risk factors for several cancers, including breast, bowel and pancreatic.

    Frontiers in Oncology 2021; Frontiers in Endocrinology 2023
EmergingEarly but promising trials. Real and fast-moving, not yet definitive.
  • Insulin resistance predicts new-onset depression: a high triglyceride-to-HDL ratio nearly doubled the risk in previously well adults.

    Watson et al., Am J Psychiatry 2021
  • The first modern trials of ketogenic and metabolic therapy in serious mental illness show improvements in both metabolic and psychiatric measures.

    Sethi et al., Psychiatry Research 2024; Edinburgh pilot, BJPsych Open 2024
  • These are mostly small, early, single-arm trials. Promising and directionally consistent, but not proof.

ContestedGenuinely debated. We present it as a hypothesis, not a fact.
  • Some researchers argue cancer is fundamentally a mitochondrial metabolic disease. The underlying Warburg effect is real, but this origin theory is a minority position; mainstream oncology treats cancer as primarily genetic with major metabolic features.

    Seyfried, J Bioenerg Biomembr 2025 (debated)

The unifying idea, stated honestly

A growing body of high-impact research argues that mitochondrial dysfunction, insulin resistance, glucose dysregulation and chronic inflammation form a shared substrate beneath many chronic diseases. We state it as a strong, evidence-backed framework, not settled fact: most chronic disease is closely linked to, and substantially driven by, metabolic dysfunction, rather than caused entirely by it.

Diaz-Vegas et al., Endocrine Reviews 2020; Zhao et al., Frontiers in Endocrinology 2023; Lopez-Otin et al., Cell 2023
Outside the cardiometabolic core and the NIH feeding trial, much of this evidence is observational, and the causal arrow is often two-way. We grade claims conservatively and update them as larger trials report. This page is education, not medical advice.
How it works

The building blocks

Those shared roots trace back to one thing you can feel day to day: how your body handles glucose. Here are eight quick, playful demos that show how it works.

01

What food does to your blood sugar

Every food here has the same amount of carbohydrate. What changes is the source, and the source decides the ride your blood sugar takes. Tap a food and watch.

Tap a food
Big spikeCornflakes · GI 81

GI (glycemic index) is how high a food drives blood sugar versus pure glucose (100). Lower means gentler. These values come from the study below.

Cornflakes shoot up. Designing breakfast cereal down is exactly what Cheeky Pete's does.
02

Your average sugar is just a number

Two days can share the exact same average and feel completely different. Drag to make the day bumpier, and watch the average refuse to move.

Drag to add swings
Average108 mg/dLunchanged
Biggest swing4 mg/dL
SteadySpiky
Same average, completely different day. The number alone cannot tell them apart, which is exactly why the swings matter next. (The average still counts too: in 308,000 adults, a higher average tracked with higher dementia risk.)
03

It is the swings that hurt

Same average, two very different rides. Flip the switch and watch the heart.

Flip the switch
Heart failure risk Low

Across 4.2 million adults, the biggest glucose swingers had a 69% higher risk of heart failure.

04

Same meal, different people

Two people eat the exact same breakfast. Watch what happens.

Press the button

APerson A

Hunger afterLow

BPerson B

Hunger afterHigh
The big dip after a spike makes you hungry sooner. Your own response even shapes your appetite.
05

Your cells run on tiny engines

Feed them steadily and they charge up. Flood them and they sputter. Flip the supply.

Flip the supply
90%
energy out
Charged
Protect the engines in every cell and you protect the whole system. That is what steady glucose does.
The bigger picture

Metabolism reaches the brain

The brain is the hungriest organ you have. So when the body's metabolism improves, the mind often does too. Here is the research.

How to read these: these are clinical trials of metabolic therapy, usually intensive ketogenic diets, and several are small or early. They are not studies of our products, and food is not a treatment for these conditions. We share them because they make one point clearly: metabolic health sits upstream of how the brain and body work.
06

Fix the metabolism, help the mind

23 adults with serious mental illness ate a metabolic diet for 4 months. Slide from start to finish.

People with metabolic syndrome 23 of 230 of 23
Slide start to finish
Weightstart
Visceral fatstart
Insulin resistancestart
Triglyceridesstart
Schizophrenia symptomsstart

Biggest changes in those who stuck closest to the diet. Small single-arm pilot, 23 people.

07

Pooling 10 studies on memory

Researchers combined 10 separate trials, 691 people with Alzheimer's. Tap to pool them.

Tap to pool
0 people with Alzheimer's, pooled across 10 trials
Memory scores went upMMSE +1.25, where higher is better
Confusion went downADAS-Cog -3.43, where lower is better

A meta-analysis pools many studies into one bigger picture. The trials varied.

08

Lifting depression

24 students with depression added a metabolic diet for 12 weeks. Press play.

Press play
100

Depression score, as a share of where they started.

-69%their own rating (PHQ-9)
-71%clinician rating (HRSD)

Improvement showed up in 2 to 6 weeks. Early single-arm pilot. Promising, not proof.

Our Scientific Director

Dr Ana Andreazza is one of the world's leading authorities on mitochondria and metabolic health.

She guides the science behind everything we build, in an advisory role grounded in scientific independence. The research on this page reflects the field she works in: how the engines inside our cells turn fuel into energy, and why steady glucose keeps them well.

Dr Ana Andreazza · Scientific Director · Advisory

References

Every demo above is drawn from recent peer-reviewed research. Full citations below, each linking to the source.

All external links verified June 2026.

01
Atkinson FS, Brand-Miller JC, Foster-Powell K, Buyken AE, Goletzke J. International tables of glycemic index and glycemic load values 2021: a systematic review. Am J Clin Nutr. 2021;114(5):1625-1632.
doi.org/10.1093/ajcn/nqab233
02
Dementia risk across distinct metabolic profiles in the UK Biobank. GeroScience. 2025. (308,019 participants; higher HbA1c associated with greater dementia risk.)
doi.org/10.1007/s11357-025-01970-6
03
Long-term glycemic variability and the risk of heart failure: a meta-analysis. PeerJ. 2025;13:e20401. (10 studies, 4,229,377 adults.)
doi.org/10.7717/peerj.20401
04
Wyatt P, Berry SE, et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nat Metab. 2021;3:523-529.
doi.org/10.1038/s42255-021-00383-x
05
The role of mitochondrial function in the pathogenesis of diabetes. Frontiers in Endocrinology. 2025. (Review.)
doi.org/10.3389/fendo.2025.1607641
06
Sethi S, Wakeham D, Ketter T, et al. Ketogenic diet intervention on metabolic and psychiatric health in bipolar and schizophrenia: a pilot trial. Psychiatry Res. 2024;335:115866.
doi.org/10.1016/j.psychres.2024.115866
07
Rong L, Peng Y, Shen Q, Chen K, Fang B, Li W. Effects of ketogenic diet on cognitive function of patients with Alzheimer's disease: a systematic review and meta-analysis. J Nutr Health Aging. 2024;28(8):100306.
pubmed.ncbi.nlm.nih.gov/38943982
08
Decker DD, Patel R, Cheavens J, et al. A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder. Transl Psychiatry. 2025.
doi.org/10.1038/s41398-025-03544-8
09
Fortier M, Castellano CA, St-Pierre V, et al. A ketogenic drink improves cognition in mild cognitive impairment: results of a 6-month randomized controlled trial. Alzheimers Dement. 2021;17(7):1119-1133.
doi.org/10.1002/alz.12206
10
Caprio M, Moriconi E, Camajani E, et al. Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial. J Transl Med. 2023;21:692.
doi.org/10.1186/s12967-023-04561-1
11
Salido-Bueno B, et al. Effects of ketogenic diets on cancer-related variables: a systematic review and meta-analysis of randomised controlled trials. Nutr Bull. 2024;49:264-277. (Evidence on tumour outcomes remains limited.)
doi.org/10.1111/nbu.12693
12
Needham N, Campbell IH, Grossi H, et al. A pilot study of a ketogenic diet in bipolar disorder: clinical, metabolic and magnetic resonance spectroscopy findings. BJPsych Open. 2025.
BJPsych Open (Cambridge Core)
13
Tidman MM, White D, White T. Effects of a low carbohydrate/healthy fat/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot study. Neurodegener Dis Manag. 2022;12(2):57-66.
doi.org/10.2217/nmt-2021-0033
14
Brenton JN, Lehner-Gulotta D, Woolbright E, et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637-644. (65 patients with relapsing MS.)
doi.org/10.1136/jnnp-2022-329074
15
Modified Atkins diet versus levetiracetam for non-surgical drug-resistant epilepsy in children: a randomized open-label study. Seizure. 2022;103:61-67. (101 children; diet superior to the drug at 12 weeks.)
pubmed.ncbi.nlm.nih.gov/36306706
16
Exploring diet-induced ketosis with exogenous ketone supplementation as a potential intervention in post-traumatic stress disorder: a feasibility study. Frontiers in Nutrition. 2024. (Feasibility study; very small sample.)
doi.org/10.3389/fnut.2024.1406366
17
The ketogenic diet in the treatment of post-concussion syndrome: a feasibility study. (Mild traumatic brain injury; 14 enrolled, 12 completed.)
ncbi.nlm.nih.gov/pmc/PMC7511571
18
Sayin O, Ilgin R, Akkaya EC, et al. Ketogenic diet mitigates age-related cognitive decline and neuroinflammation in rats. Journal of Molecular Neuroscience. 2025;75:114. (Animal study, aged rats.)
doi.org/10.1007/s12031-025-02401-z
19
Bueno NB, de Melo ISV, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110(7):1178-1187. (13 RCTs.)
pubmed.ncbi.nlm.nih.gov/23651522
20
Ketogenic diet in steatotic liver disease: a metabolic approach to hepatic health. Nutrients. 2025;17(7):1269. (Review; long-term data still limited.)
doi.org/10.3390/nu17071269
21
Effects of ketogenic diets on polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology and Endocrinology. 2025. (Heterogeneity warrants cautious interpretation.)
doi.org/10.1186/s12958-025-01411-1
22
Beta-hydroxybutyrate and ischemic stroke: roles and mechanisms. Molecular Brain. 2024;17:53. (Neuroprotection shown mainly in animal and cell models; human evidence preliminary.)
doi.org/10.1186/s13041-024-01119-0

This page is for education. It explains published research and is not medical advice. Individual results vary; speak to a qualified professional about your own health. Figures in the interactive demos are illustrative unless a specific study value is cited.